Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIODARONE vs RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIODARONE vs RIBOCICLIB: Safety Overview

Metric AMIODARONE RIBOCICLIB
Total FAERS Reports 25,143 27,997
Deaths Reported 3,845 4,501
Death Rate 15.3% 16.1%
Hospitalizations 13,711 6,700
Average Patient Age 69.9 yrs 60.2 yrs
% Female Patients 36.9% 99.0%
FDA Approval Date Apr 12, 2005 Mar 13, 2017
Manufacturer Aurobindo Pharma Limited Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Discontinued Prescription